| Mark L Davidner, MD | |
|
1000 E 101st Ter, Kansas City, MO 64131-3366 | |
| (816) 333-1326 | |
| (816) 333-0086 |
| Full Name | Mark L Davidner |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Hematology & Oncology |
| Location | 1000 E 101st Ter, Kansas City, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598737058 | NPI | - | NPPES |
| 100176810D | Medicaid | KS | |
| 1598737058 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 35308 (Missouri) | Primary |
| 207RH0003X | Internal Medicine - Hematology & Oncology | 04-19533 (Kansas) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Mark L Davidner, MD 9200 Indian Creek Pkwy, Building 9, Suite 300, Overland Park, KS 66210-2002 Ph: (913) 541-4600 | Mark L Davidner, MD 1000 E 101st Ter, Kansas City, MO 64131-3366 Ph: (816) 333-1326 |
News Archive
OncoMed Pharmaceuticals, Inc., a company developing novel therapeutics that target cancer stem cells or tumor-initiating cells, today announced that the FDA has accepted an IND filing for OMP-18R5, which allows OncoMed to commence Phase 1 clinical testing.
Inova Health System's Military to Medicine program is hosting a national launch event on Tuesday, April 20, at the National Press Club to announce the program will be providing healthcare training and career opportunities to military families across the country.
Punitive policies intended to reduce drug use by making life difficult for convicted users are counterproductive and actually lead to a vicious spiral of drug use and reincarceration.
"Declining malaria deaths in Africa and progress toward an effective malaria vaccine are raising hopes the disease will soon be eradicated worldwide," but "researchers at the annual meeting of the American Society of Tropical Medicine and Hygiene (ASTMH) in Philadelphia, Pennsylvania, [on Monday] unveiled a new global malaria map that raises new concerns about the disease," VOA News writes.
Ground-breaking results from researchers at Harvard Medical School and Massachusetts Institute of Technology (MIT), USA, disclosed at the 13th European Cancer Conference (ECCO) in Paris have shown for the first time that targeted drug delivery is possible using nanoparticle-apatamer conjugates.
› Verified 8 days ago
Maria Akram Sheikh, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 4401 Wornall Rd, Kansas City, MO 64111 Phone: 816-932-0340 Fax: 816-932-3148 | |
Dr. Philip Barigbi Augustine, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 4150 N Mulberry Dr, Kansas City, MO 64116 Phone: 816-912-4539 Fax: 855-813-6642 | |
Lucas Vocelka, DO Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2340 E Meyer Blvd, Bldg 2, Suite 392, Kansas City, MO 64132 Phone: 816-444-7977 Fax: 630-528-9578 | |
Karla L Houston-gray, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1004 Carondelet Dr Ste 300, Kansas City, MO 64114 Phone: 816-942-4500 Fax: 816-941-4504 | |
Carl D Dirks, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 4320 Wornall Rd, Suite 65, Kansas City, MO 64111 Phone: 816-932-6100 Fax: 816-932-9002 | |
Michelle L Dew, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 4330 Wornall Rd, Suite 2000, Kansas City, MO 64111 Phone: 816-931-1883 Fax: 816-756-3645 | |
Brenda J Rogers, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2401 Gillham Rd, Kansas City, MO 64108 Phone: 816-234-3000 |